Learn More
OBJECTIVE To evaluate the safety and pharmacokinetics of multiple infusions of a humanized anti-interleukin-6 (IL-6) receptor antibody, MRA, in patients with rheumatoid arthritis (RA). METHODS In(More)
To investigate the mechanism of the long-lasting efficacy of chimeric monoclonal anti-TNFα antibody (cA2) therapy for rheumatoid arthritis (RA), eight patients with refractory RA were treated with a(More)